1. Raunio, H., Husgafvel-Pursiainen, K., Anttila, S., Hietanen, E., Hirvonen, A., and Pelkonen, O. Diagnosis of polymorphisms in carcinogen-activaitng and inactivating enzymes and cancer susceptibility-a review. Gene 159: 113–121 (1995).
2. Swift, M., Morrell, D., Massey, R.B., and Chase, C.L. Incidence of cancer in 161 families affected by ataxia-teleangiectasia. N. Engl. J. Med. 325: 1831–1836 (1991).
3. Vainio, H. Biomarkers in metabolic subtyping-Relevance for environmental cancer control. Arch. Toxicol. (Suppl. 20 ): 303–310 (1998).
4. Kleihues, P., Schauble, B., zur Hausen, A., Esteve, J., and Ohkagi, H. Tumors associated with p53 germline mutations: a synopsis of 91 families. Am. J. Pathol. 150: 1–13 (1997).
5. Li, F.P. The 4`h American Cancer Society Award for Research Excellence in Cancer Epidemiology and Prevention. Phenotypes, genotypes, and interventions for hereditary cancers. Cancer Epidem. Biomarkers Prey. 4: 579–582 (1995).